Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio Growth (3y) (2016 - 2026)
Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -28.01% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 41.72% |
| 10 | Amphastar Pharmaceuticals | 855.23 Mn | 684.09 Mn | 70.32 Mn | -58.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.87% |
| Dec 31, 2025 | -37.17% |
| Sep 30, 2025 | 42.59% |
| Jun 30, 2025 | 127.54% |
| Mar 31, 2025 | -48.51% |
| Dec 31, 2024 | -52.36% |
| Sep 30, 2024 | -22.96% |
| Jun 30, 2024 | 24.18% |
| Mar 31, 2024 | -35.38% |
| Dec 31, 2023 | -224.81% |
| Sep 30, 2023 | 16.30% |
| Jun 30, 2023 | 26.27% |
| Mar 31, 2023 | 26.14% |
| Dec 31, 2022 | 327.61% |
| Sep 30, 2022 | 72.17% |
| Jun 30, 2022 | 122.40% |
| Mar 31, 2022 | 130.20% |
| Dec 31, 2021 | -54.62% |
| Sep 30, 2021 | 144.15% |
| Jun 30, 2021 | 50.37% |